tazemetostat (Tazverik) Report issue

Small molecule Orphan Drug FDA Approved FDA Accelerated Approval FDA Priority Review FDA
AACT DrugBank PubChem
Back

Drug Pricing Summary

VA FSS

$47.8581

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
tazemetostat hydrobromide 200 mg (TABLET) $47.8581 VA FSS
  • TAZVERIK (240)
    		•  Epizyme, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue